200. Epidemiology. 2018 Sep;29(5):e39-e40. doi: 10.1097/EDE.0000000000000853.Re: Beta Blockers and Improved Progression-Free Survival in Patients WithAdvanced HER2 Negative Breast Cancer.Sørensen GV(1), Cronin-Fenton DP, Sørensen HT, Damkier P, Ejlertsen B,Christiansen PM, Lash TL, Ahern TP.Author information: (1)Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus,Denmark, gitte@clin.au.dk Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark Department of Clinical Biochemistry and Pharmacology,Odense University Hospital, Odense, Denmark Danish Breast Cancer CooperativeGroup, Rigshospitalet, Copenhagen, Denmark Danish Breast Cancer CooperativeGroup, Rigshospitalet, Copenhagen, Denmark Breast Unit Surgical Department,Randers Regional Hospital, Randers, Denmark Department of Plastic and BreastSurgery, Aarhus University Hospital, Aarhus, Denmark Department of ClinicalEpidemiology, Aarhus University Hospital, Aarhus, Denmark, Department ofEpidemiology, Rollins School of Public Health and Winship Cancer Institute, EmoryUniversity, Atlanta, GA Departments of Surgery and Biochemistry, Larner Collegeof Medicine, University of Vermont, Burlington, VT.DOI: 10.1097/EDE.0000000000000853 PMID: 29771735 